What This Evaluation Is
Autism Spectrum Disorder is a complex neurodevelopmental condition with highly individualized presentations, support needs, and medical considerations. Some individuals and families explore regenerative medicine because of ongoing scientific interest in:
- Inflammatory Signaling
- Immune System Regulation
- Cellular Communication
- Neurologic Recovery Pathways
- Metabolic and Systemic Health Factors
Exosomes are biologic materials involved in cellular signaling and regenerative medicine research. These therapies are being studied across multiple areas of medicine for how they may interact with inflammatory and immune pathways. At Nuvo Med, exosome therapies are discussed cautiously, ethically, and within the context of comprehensive medical evaluation.
What Is Reviewed During Evaluation
When Autism Spectrum Disorder is part of the medical history, evaluation may include discussion of:
- Neurologic Context
- Prior Therapies and Interventions
- Medications and Supplements
- Overall Health Status
- Functional Concerns and Realistic Goals
The consultation is designed to determine whether regenerative medicine topics are appropriate to discuss based on:
- Safety
- Medical History
- Current Evidence
- Realistic Expectations
- Overall Clinical Context
rEGENERATIVE therapies are:
- Not FDA-Approved for Autism Spectrum Disorder
- Not Presented as a Cure For ASD
- Not Guaranteed to Provide Benefit
- Not Appropriate for Every Individual
The purpose of consultation is to help individuals and families better understand:
- The Current Research Landscape
- Medical Considerations
- Safety Factors
- Limitations and Uncertainties
- Whether Further Discussion is Medically Appropriate
How exosomes ARE DISCUSSED
Exosomes are naturally occurring biologic components involved in cellular communication. Researchers continue studying how these biologic materials may influence:
Exosomes contain:
While exosome therapies involve biologic cells being explored in regenerative medicine research. Within the context of ASD, these therapies remain investigational and scientifically evolving.
Nuvo Med does not present stem cell or exosome therapies as established ASD treatments and avoids overstating what current research can support.

What to Expect During Consultation
Before
Patients may be asked to provide:
- Medical Records
- Diagnostic History
- Medication Lists
- Laboratory Results When Available
- Prior Treatment History
During
Consultation includes:
- Detailed Medical History Review
- Discussion of Current Concerns and Goals
- Review of Risks and Limitations
- Explanation of Current Regenerative Medicine Research
- Discussion of Regulatory and Safety Considerations
The visit is informational and evaluative.
After
Some individuals may:
- Pursue Further Evaluation
- Decide Against Regenerative Therapies
- Be Advised That Treatment is not Appropriate
- Discuss Alternative Supportive Care Strategies
Recommendations are individualized and based on physician judgment.

Related Concerns
Frequently asked questions
Are stem cell or exosome therapies FDA-approved for Autism Spectrum Disorder?
No. These therapies are not FDA-approved for the treatment of Autism Spectrum Disorder.
Does consultation mean treatment will be recommended?
No. Consultation is designed to determine whether regenerative medicine discussion is medically appropriate.
Are results predictable?
No. Responses to biologic therapies are highly individualized and uncertain.
Are stem cells and exosomes being studied scientifically?
Yes. Researchers continue studying how biologic signaling therapies may interact with inflammatory and immune pathways across multiple areas of medicine.
Is this consultation for children or adults?
Evaluations are individualized and depend on:
- physician judgment
- age
- medical history
- overall health status
- safety considerations
Still got questions?

More Treatments

Start With a
Professional Assessment
Schedule a consultation to discuss stem cells, exosomes, regenerative medicine research, and whether biologic therapy discussions are appropriate within the context of Autism Spectrum Disorder and your individual medical situation.
THIS NOTICE MUST BE PROVIDED TO YOU UNDER WASHINGTON LAW. This health care practitioner performs one or more stem cell therapies that have not yet been approved by the United States food and drug administration. You are encouraged to consult with your primary care provider prior to undergoing a stem cell therapy